您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报 (医学版) ›› 2023, Vol. 61 ›› Issue (2): 57-64.doi: 10.6040/j.issn.1671-7554.0.2022.1004

• 临床医学 • 上一篇    下一篇

934例甲状腺微小乳头状癌颈淋巴结部位转移及危险因素

邵长秀1,2,贺青卿2,庄晓璇3,李小磊2,周鹏2,岳涛2,高远2,4,徐婧2,李陈钰1,2,郭浩男1,2,庄大勇2   

  1. 1.锦州医科大学中国人民解放军联勤保障部队第九六〇医院研究生培养基地, 山东 济南 250031;2.中国人民解放军联勤保障部队第九六〇医院甲状腺乳腺外科, 山东 济南 250031;3.重庆医科大学国际医学院, 重庆 400016;4.中国人民解放军联勤保障部队第九六三医院, 黑龙江 佳木斯 154002
  • 发布日期:2023-02-17
  • 通讯作者: 庄大勇. E-mail:zdyddy2000@TOM.com

Patterns and risk factors of cervical lymph node metastasis in 934 cases of papillary thyroid microcarcinoma

SHAO Changxiu1,2, HE Qingqing2, ZHUANG Xiaoxuan3, LI Xiaolei2, ZHOU Peng2, YUE Tao2, GAO Yuan2,4, XU Jing2, LI Chenyu1,2, GUO Haonan1,2, ZHUANG Dayong2   

  1. 1. Postgraduate Training Base of the 960th Hospital of PLA Joint Logistics Support Force of Jinzhou Medical University, Jinan 250031, Shandong, China;
    2. Department of Thyroid and Breast Surgery, The 960th Hospital of PLA Joint Logistics Support Force, Jinan 250031, Shandong, China;
    3. International Medical College of Chongqing Medical University, Chongqing 400016, China;
    4. The 963th Hospital of PLA Joint Logistics Support Force, Jiamusi 154002, Heilongjiang, China
  • Published:2023-02-17

PDF (PC)

427

摘要： 目的 探讨甲状腺微小乳头状癌(PTMC)颈部淋巴结转移规律及危险因素分析, 为合理、规范的外科手术提供临床依据。 方法 回顾性分析2019年1月至2021年12月解放军第九六〇医院病理科接收的行颈侧区淋巴结清扫的甲状腺微小乳头状癌患者934例病理资料。统计患者颈部淋巴结转移情况,分析患者不同临床特征与颈部淋巴结转移之间的关系以及颈部淋巴结转移的危险因素。 结果 934例甲状腺微小乳头状癌患者中,颈部淋巴结(中央区和/或颈侧区)转移率50.64%(473/934),中央区淋巴结转移率47.86%(447/934),颈侧区淋巴结转移率20.77%(194/934)。447例中央区转移患者中168例(37.58%)合并颈侧区淋巴结转移。颈侧区淋巴结转移而中央区无转移率2.78%(26/934)。卡方检验分析显示,男性、肿瘤直径>0.55cm、包膜侵犯、双侧、多灶的PTMC患者颈部淋巴结、颈部中央区淋巴结、颈侧区淋巴结转移率高(P<0.05),不合并桥本甲状腺炎的PTMC患者颈部及颈部中央区淋巴结转移率高(P<0.05),特殊病理类型的PTMC患者颈部及颈侧区淋巴结转移率高(P<0.05);二分类Logistic多因素回归分析显示,男性、肿瘤直径>0.55 cm、双侧、不合并桥本甲状腺炎是颈部及颈部中央区淋巴结转移的独立危险因素;肿瘤直径>0.55 cm、包膜侵犯、特殊病理类型为颈侧区淋巴结转移的独立危险因素。单病灶甲状腺微小乳头状癌患者肿瘤位置位于上部及峡部时侧区淋巴结转移率高于中部和下部。 结论 PTMC患者中央区淋巴结转移率高,应常规行中央区淋巴结清扫。当PTMC患者存在肿瘤直径>0.55 cm、包膜侵犯、特殊病理类型、肿瘤位于上部或峡部时,颈侧区淋巴结转移风险增高,可考虑行颈侧区淋巴结清扫。

关键词: 甲状腺微小乳头状癌, 颈部淋巴结转移, 转移率, 危险因素

Abstract: Objective To explore the patterns and risk factors of cervical lymph nodes metastasis(LNM)of papillary thyroid microcarcinoma(PTMC), in order to provide clinical evidences for reasonable and standardized surgical procedures. Methods Pathological data of 934 PTMC patients who underwent lateral lymph node dissection during Jan. 2019 and Dec. 2021 were retrospectively analyzed. The cervical LNM data were collected. The relationship between cervical LNM and different clinical characteristics and risk factors of LNM were analyzed. Results Among the 934 patients, the rate of central and/or lateral LNM was 50.64%(473/934); the rates of central and lateral LNM were 47.86%(447/934)and 20.77%(194/934), respectively. Among the 447 patients with central LNM, 168(37.58%)also had lateral LNM. The rate of lateral LNM without central LNM was 2.78%(26/934). Chi-square analysis showed that male, tumor diameter larger than 0.55 cm, extracapsular invasion, bilateral cancer, and multifocality were related to higher rate of cervical LNM, central LNM and lateral LNM(P<0.05); patients without Hashimotos thyroiditis had higher rate of cervical LNM and central LNM(P<0.05); patients of specific pathological types had higher rate of cervical LNM and lateral LNM(P<0.05). The binary multivariate Logistic regression analysis showed that male, tumor diameter larger than 0.55 cm, bilateral cancer, and without Hashimotos thyroiditis were independent risk factors of cervical LNM and central LNM; tumor diameter larger than 0.55 cm, extracapsular invasion, and specific pathological subtypes were independent risk factors of lateral LNM. For PTMC patients with single foci, the rate of lateral LNM was higher when the tumor was located in the upper pole of glands and isthmus than in the middle and lower. Conclusion PTMC patients with high probability of central LNM should receive regular central lymph node dissection. For patients with tumor diameter larger than 0.55cm, extracapsular invasion, specific pathological subtypes, and tumor located in the upper pole or isthmus, there is an increased risk of lateral LNM, and lateral lymph node dissection can be considered.

Key words: Papillary thyroid microcarcinoma, Cervical lymph node metastasis, Metastasis rate, Risk factors

中图分类号: 

  • R736.1
[1] 中国临床肿瘤学会指南工作委员会, 黄慧强, 林岩松, 等. 中国临床肿瘤学会(CSCO)分化型甲状腺癌诊疗指南2021[J]. 肿瘤预防与治疗, 2021, 34(12): 1164-1201. Guidelines Working Committee of Chinese Society of Clinical Oncology, HUANG Huiqiang, LIN Yansong, et al. Guidelines of Chinese society of clinical oncology(CSCO)differentiated thyroid cancer [J]. Journal of Cancer Control and Treatment, 2021, 34(12): 1164-1201.
[2] Lee YS, Lim YS, Lee JC, et al. Ultrasonographic findings relating to lymph node metastasis in single micropapillary thyroid cancer [J]. World J Surg Oncol, 2014, 12: 273. doi: 10.1186/1477-7819-12-273.
[3] Hwang HS, Orloff LA. Efficacy of preoperative neck ultrasound in the detection of cervical lymph node metastasis fromthyroid cancer Laryngoscope [J]. Laryngoscope, 2011, 121(3): 487-491.
[4] Mansour J, Sagiv D, Alon E, et al. Prognostic value of lymph node ratio in metastatic papillary thyroid carcinoma [J]. J Laryngol Otol, 2018, 132(1): 8-13.
[5] Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer [J]. Thyroid, 2016, 26(1): 1-133.
[6] Perros P, Boelaert K, Colley S, et al. Guidelines for the management of thyroid cancer [J]. Clin Endocrinol(Oxf), 2014, 81(Suppl 1): 1-122.
[7] 中国抗癌协会甲状腺癌专业委员会(CATO). 甲状腺微小乳头状癌诊断与治疗中国专家共识(2016版)[J]. 中国肿瘤临床, 2016, 43(10): 405- 411. Chinese Association of Thyroid Oncology. Chinese Expert Consensus on Diagnosis and Treatment of Papillary Thyroid Microcarcinoma(2016 Edition)[J]. Chinese Journal of Clinical Oncology, 2016, 43(10): 405-411.
[8] Miyauchi A, Ito Y. Conservative surveillance management of low-risk papillary thyroid microcarcinoma [J]. Endocrinol Metab Clin North Am, 2019, 48(1): 215-226.
[9] Hay ID, Hutchinson ME, Gonzalez-Losada T, et al. Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period [J]. Surgery, 2008, 144(6): 980-987.
[10] Cho SY, Lee TH, Ku YH, et al. Central lymph node metastasis in papillary thyroid microcarcinoma can be stratified according to the number, the size of metastatic foci, and the presence of desmoplasia [J]. Surgery, 2015, 157(1): 111-118.
[11] Huang XP, Ye TT, Zhang L, et al. Sonographic features of papillary thyroid microcarcinoma predicting high-volume central neck lymph node metastasis [J]. Surg Oncol, 2018, 27(2): 172-176.
[12] Kim SY, Lee E, Nam SJ, et al. Ultrasound texture analysis: association with lymph node metastasis of papillary thyroid microcarcinoma [J]. PLoS One, 2017, 12(4): e0176103.
[13] Luo Y, Zhao Y, Chen K, et al. Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma [J]. J Endocrinol Invest, 2019, 42(2): 227-236.
[14] 伏桂明, 王朝晖, 陈义波, 等. 甲状腺微小乳头状癌合并桥本氏甲状腺炎的临床特点及CLNM危险因素分析[J]. 中华内分泌外科杂志, 2020, 14(4): 274-278. FU Guiming, WANG Zhaohui, CHEN Yibo, et al. Clinical characteristics of papillary thyroid micro-carcinoma with Hashimotos thyroiditis and analysis of CLNM risk factors[J]. Chinese Journal of Endocrine Surgery, 2020, 14(4): 274-278.
[15] Zhao W, Chen S, Hou X, et al. Predictive factors of lateral lymph node metastasis in papillary thyroid microcarcinoma [J]. Pathol Oncol Res, 2019, 25(3): 1245-1251.
[16] Chow SM, Law SC, Chan JK, et al. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality [J]. Cancer, 2003, 98(1): 31-40.
[17] Ito Y, Tomoda C, Uruno T, et al. Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid [J]. World J Surg, 2006, 30(1): 91-99.
[18] Kwak JY, Kim EK, Kim MJ, et al. Papillary microcarcinoma of the thyroid: predicting factors of lateral neck node metastasis [J]. Ann Surg Oncol, 2009, 16(5): 1348-1355.
[19] Yin X, Liu C, Guo Y, et al. Influence of tumor extent on central lymph node metastasis in solitary papillary thyroid microcarcinomas: a retrospective study of 1092 patients [J]. World J Surg Oncol, 2017, 15(1): 133.
[20] Kim K, Zheng X, Kim JK, et al. The contributing factors for lateral neck lymph node metastasis in papillary thyroid microcarcinoma(PTMC)[J]. Endocrine, 2020, 69(1): 149-156.
[21] Xu S, Huang H, Qian J, et al. Prevalence of Hashimoto thyroiditis in adults with papillary thyroid cancer and its association with cancer recurrence and outcomes [J]. JAMA Netw Open, 2021, 4(7): e2118526.
[22] Zou Q, Ma S, Zhou X. Association of sonographic features and clinicopathologic factors of papillary thyroid microcarcinoma for prevalence of lymph node metastasis: a retrospective analysis [J]. Arch Endocrinol Metab, 2021, 64(6): 803-809.
[23] Back K, Kim JS, Kim JH, et al. Superior located papillary thyroid microcarcinoma is a risk factor for lateral lymph node metastasis[J]. Ann Surg Oncol, 2019, 26(12): 3992-4001.
[24] Zhou L, Gao C, Li H, et al. Isthmic papillary thyroid carcinoma presents a unique pattern of central lymph node metastasis [J]. Cancer Manag Res, 2020, 12: 3643-3650. doi: 10.2147/CMAR.S252692.
[25] 孙芸, 陈亮, 沈亦斌, 等. 峡部甲状腺微小乳头状癌临床病理特征及淋巴结转移危险因素分析[J]. 中华内分泌外科杂志, 2021, 15(3): 278-282. SUN Yun, CHEN Liang, SHEN Yibin, et al. Clinicopathological characteristics and risk factors of lymph node metastasis in isthmus papillary thyroid microcarcinoma [J]. Chinese Journal of Endocrine Surgery, 2021, 15(3): 278-282.
[26] Zhao H, Huang T, Li H, et al. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer [J]. Surgery, 2019, 166(1): 55-60.
[27] Kim YS. Patterns and predictive factors of lateral lymph node metastasis in papillary thyroid microcarcinoma [J]. Otolaryngol Head Neck Surg, 2012, 147(1): 15-19.
[28] 时晶晶, 丁金旺, 彭友, 等. 乳头状甲状腺微小癌跳跃性侧颈淋巴结转移的临床风险因素分析及模型预测[J]. 中华实验外科杂志, 2020, 37(12): 2289-2291. SHI Jingjing, DING Jinwang, Peng You, et al. Clinical risk factors analysis and model prediction of skip lateral cervical lymph node metastasis in papillary thyroid microcarcinoma [J]. Chinese Journal of Experimental Surgery, 2020, 37(12): 2289-2291.
[29] Hu D, Lin H, Zeng X, et al. Risk factors for and prediction model of skip metastasis to lateral lymph nodes in papillary thyroid carcinoma [J]. World J Surg, 2020, 44(5): 1498-1505.
[1] 黄玉真,吕琛,颜磊,李帅帅,张景雪,刘超,王银霞,桑岩岩,房鹛. 基于危险因素筛查的延续性院外管理对卵巢过度刺激综合征的预防效果[J]. 山东大学学报 (医学版), 2026, 64(4): 92-99.
[2] 逄锦宏,苏萍,乔俊鹏,陈巧巧,陈学禹,赵颖颖,施婕,孙晓茹,李秋春,何蕊言,范轶欧,迟蔚蔚. 老年人群可改变心血管危险因素聚集模式与脑卒中的关联[J]. 山东大学学报 (医学版), 2025, 63(9): 11-19.
[3] 张政,王建伟,杨玉娟,张宇,宋西成. 哮喘儿童2008及2019年免疫球蛋白E变化及相关危险因素[J]. 山东大学学报 (医学版), 2025, 63(7): 32-36.
[4] 李敬,郝盼盼. 急性心力衰竭患者出入院心率变化与预后相关性[J]. 山东大学学报 (医学版), 2025, 63(4): 75-82.
[5] 程震宇,来庆国,吴梦涛. 髂股静脉支架置入术后再狭窄的影响因素研究进展[J]. 山东大学学报 (医学版), 2025, 63(12): 112-117.
[6] 程跃启,王斐,于理想,郑超,余之刚. 曲妥珠单抗致HER2阳性乳腺癌患者心脏毒性的研究进展[J]. 山东大学学报 (医学版), 2025, 63(1): 17-24.
[7] 王浙宇,许懿,赵昌波,杨硕菲,倪其泓,陈佳佺,王韦仑,李一男,郭相江,叶猛,张岚,薛冠华. 腹主动脉瘤腔内修复术后发生髂支闭塞的危险因素及处理对策[J]. 山东大学学报 (医学版), 2024, 62(9): 101-107.
[8] 郭鑫,孟君,郑世良,董秀红. 老年胃癌患者衰弱与人体成分的相关性[J]. 山东大学学报 (医学版), 2024, 62(4): 40-47.
[9] 李建,孙云. 新入维持性血液透析患者2年内死亡的危险因素[J]. 山东大学学报 (医学版), 2024, 62(4): 48-53.
[10] 宋甜田,李作坤,王书会. 个体化预测老年心脏瓣膜置换术后医院感染风险Nomogram模型的构建[J]. 山东大学学报 (医学版), 2024, 62(1): 48-56.
[11] 曲永强,赵泽宇,吴兴原,韩玮,段瑞生,李衍滨,李亨. 颈动脉分叉处支架置入术后严重持续性低血压的危险因素[J]. 山东大学学报 (医学版), 2023, 61(7): 78-82.
[12] 宋晗,王振华,韦铎亮,徐凯,李博文,赵鑫. 术前MELD分级对304例急性StandfordA型主动脉夹层患者术后早期结局的影响[J]. 山东大学学报 (医学版), 2023, 61(5): 31-36.
[13] 张蒙,马伟. 1990—2019年中国人类免疫缺陷病毒/获得性免疫缺陷综合征流行趋势及疾病负担[J]. 山东大学学报 (医学版), 2023, 61(5): 84-89.
[14] 穆彦熹,李金洲,陈康,梁红英,姚亚龙,汪文杰,陈晓. 443例胃癌根治术后发生肺部并发症的危险因素[J]. 山东大学学报 (医学版), 2023, 61(4): 37-41.
[15] 王园园,孙云. 合并新型冠状病毒肺炎的维持性血液透析患者死亡危险因素[J]. 山东大学学报 (医学版), 2023, 61(11): 68-73.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发